Publications by authors named "Y G Sidneva"

Pituitary carcinoma (metastatic neuroendocrine tumor of the pituitary gland) is the pituitary tumor with confirmed craniospinal and/or systemic metastases. These tumors are extremely rare accounting for only 0.1% to 0.

View Article and Find Full Text PDF

Background: Treatment of patients with prolonged and permanent disturbance of consciousness is still an extremely difficult problem. Nowadays, management is based on pathophysiological and molecular mechanisms of impaired consciousness. Several electrophysiological and pharmacological methods were proposed to restore consciousness in appropriate patients.

View Article and Find Full Text PDF
Article Synopsis
  • Treatment for acromegaly remains challenging, with remission rates varying from 34% to 85%, depending on tumor type, emphasizing the need to identify factors that could predict surgical success.
  • A retrospective study of 227 patients showed that 55% achieved remission post-surgery, with noticeable decreases in growth hormone and IGF-1 levels over time.
  • Key predictors for successful remission included younger age, lower preoperative growth hormone levels, smaller tumor size, and absence of residual tumor, along with early postoperative hormone levels.
View Article and Find Full Text PDF

Background: Chordoid glioma is a rare slow-growing tumor of the central nervous system. Available world experience includes no more than 200 cases (lesion of the third ventricle in absolute majority of cases). Recognition and treatment of chordoid glioma are currently difficult problems due to small incidence of this disease.

View Article and Find Full Text PDF

Reset osmostat syndrome (ROS) is characterized by a change of normal plasma osmolality threshold (decrease or increase), which leads to chronic dysnatremia (hypo- or hypernatremia). We have described a clinical case of ROS and chronic hyponatremia in a patient with chordoid glioma of the III ventricle. It is known that the patient had previously been diagnosed with hyponatremia (131-134 mmol/l).

View Article and Find Full Text PDF